Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Analytical and quantitative cytology and histology

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16121635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters

  2005cited by this paper
• Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.

  2005cited by this paper
• Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma.

  2004cited by this paper
• Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.

  2004cited by this paper
• Genetic instability and transitional cell carcinoma of the bladder

  2004cited by this paper
• Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses

  2003cited by this paper
• Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder

  2002cited by this paper
• Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium

  2002cited by this paper
• Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.

  2002cited by this paper
• Bladder cancer. I. Molecular and genetic basis of carcinogenesis.

  2001cited by this paper
• Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells.

  2001cited by this paper
• Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.

  2001cited by this paper
• Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications

  2001cited by this paper
• Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.

  2001cited by this paper
• Genetic modeling of human urinary bladder carcinogenesis

  2000cited by this paper
• Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder

  2000cited by this paper
• Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding

  1999cited by this paper
• Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer.

  1999cited by this paper
• Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.

  1999cited by this paper
• Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).

  1999cited by this paper
• Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome‐9 deletion

  1998cited by this paper
• Chromosomal aberrations associated with invasion in papillary superficial bladder cancer

  1998cited by this paper
• Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.

  1997cited by this paper
• Papillary urothelial hyperplasia. A precursor to papillary neoplasms.

  1996cited by this paper
• Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder.

  1996cited by this paper
• Molecular genetics of bladder cancer.

  1995cited by this paper
• Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.

  1993cited by this paper

• Flat intraurothelial lesions of the urinary bladder—do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice

  2022cites this paper
• Neoplasms of the Urinary Bladder

  2020cites this paper
• Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm

  2018cites this paper
• Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.

  2018cites this paper
• Dysplasia and carcinoma in situ of the urinary bladder.

  2015cites this paper
• Bladder cancer: Normal cystoscopy, malignant cytology in NMIBC: why biopsy?

  2014cites this paper
• Urothelial dysplasia of the bladder: diagnostic features and clinical significance.

  2013cites this paper
• A QC H ANALY TICAL AND QUANTITATIVECYTOPATHOLOGY AND HISTOPATHOLOGY ® Urothelial Dysplasia of the Bladder Diagnostic Features and Clinical Significance

  2013cites this paper
• Pathology of flat bladder lesions with emphasis on putative precursors

  2013cites this paper
• Bladder Cancer: General Features

  2012cites this paper
• Bladder cancer: translating molecular genetic insights into clinical practice.

  2011cites this paper
• The origins of urothelial carcinoma

  2010cites this paper
• The origins of urothelial

  2010cites this paper
• Loss of heterozygosity at 9q32–33 (DBC1 locus) in primary non‐invasive papillary urothelial neoplasm of low malignant potential and low‐grade urothelial carcinoma of the bladder and their associated normal urothelium

  2008cites this paper
• Review. Non-papillary urothelial lesions of the urinary bladder: morphological classification and immunohistochemical markers.

  2008cites this paper
• Allelic Imbalance Analysis Using a Single-Nucleotide Polymorphism Microarray for the Detection of Bladder Cancer Recurrence

  2008cites this paper
• Urothelial Dysplasia and Its Mimics

  2008cites this paper
• Immunohistochemical markers in evaluation of urinary and bladder tumors.

  2007cites this paper
• Morphometry of urinary atypical cells.

  2007cites this paper
• Kidney cancer: not a single disease.

  2007cites this paper
• FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

  2007cites this paper
• Analytical and Qualitative Cytology and Histology. Reflection on the past two years.

  2007cites this paper
• Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review.

  2007cites this paper
• Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.

  2007cites this paper
• The S100 proteins for screening and prognostic grading of bladder cancer.

  2007cites this paper
• The concept of structural entropy in tissue-based diagnosis.

  2007cites this paper
• Editorial comment on: FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

  2007cites this paper
• "Field cancerization" in the urothelium of the bladder.

  2006cites this paper
• Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder

  2006cites this paper
• Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer

  2006cites this paper